EOErnest Osei

Ernest Osei

*This is an algorithmically generated author record based on publicly available information.

Ernest Osei has a total of 175 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Shoulder muscle radiation dose: Impact of radiation technique and patient positioning during breast radiotherapy

    by Tea Lulic-Kuryllo, Nolan Hutton, Ayesha Vavda, Mia Fluit, Nizar Saadeldeen, Johnson Darko, Ernest Osei

    Introduction: Radiotherapy (RT) is a highly effective breast cancer treatment. However, RT can deliver radiation dose to the healthy tissues of the shoulder, increasing the potential for long-term shoulder morbidity. This study compared the dose delivered to key shoulder muscles between common RT techniques and patient positioning. Methods: The treatment plans of 54 patients were analysed, including those treated in the prone and supine positions. Eight shoulder muscles were contoured on each patient’s computer tomography scan. The following breast treatment techniques were analysed: hybrid-intensity-modulated RT (hybrid IMRT), wedged field, two partial arcs volumetric-modulated arc therapy (VMAT), hybrid VMAT, and 3-field supraclavicular technique. Moreover, the effect of patient positioning was also evaluated (supine versus prone). Muscle radiation exposure was compared for the mean dose and the percent muscle volume exposed to V 15 Gy and V 30 Gy. Results: The mean dose and exposed volume for the pectoralis major and pectoralis minor were similar between hybrid IMRT, wedged field, VMAT, and hybrid VMAT. VMAT and hybrid VMAT delivered a greater mean dose to most posterior shoulder muscles compared to hybrid IMRT, though overall exposure remained generally low for these muscles. The 3-field supraclavicular technique increased radiation exposure to all shoulder muscles, particularly to the pectoralis major, the pectoralis minor and the supraspinatus. Prone positioning significantly reduced V 15 Gy and V 30 Gy exposure for both anterior and posterior shoulder muscles. Conclusion: Shoulder muscle exposure was similar between hybrid IMRT, wedged field, VMAT and hybrid VMAT. The anterior shoulder muscles were consistently exposed to radiation with all RT techniques investigated in this study. In comparison, the 3-field supraclavicular technique substantially increased the radiation exposure to the posterior shoulder muscles. Lastly, delivering radiation in the prone position spared the anterior and posterior shoulder muscles. These findings inform treatment planning decisions aimed at mitigating the risk of long-term shoulder dysfunction.

  • Open Access

    Post-treatment recovery of docetaxel-treated prostate cancer monolayer and spheroid culture

    by Steph Swanson, Catherine B. McKenna, Elahe Cheraghi, Ernest Osei

    In the last half-century, it has become widely recognized that small 3D aggregates of cancer cells called tumor spheroids mimic some aspects of tumor behavior. Cell culture geometry has been shown to influence drug pharmacokinetics, delivery, and resistance. Despite the improved physiological relevance, the laborious nature of spheroids has limited clonogenic measurement and longitudinal observation of post-treatment recovery in docetaxel-treated prostate tumor spheroids. Agent-based modeling can complement spheroid experiments by probing questions of interest that are experimentally inaccessible. Here, we performed proliferation and clonogenic assays in docetaxel-treated PC3 cells cultured in monolayers and spheroids to assess and compare end-of-treatment survival and post-treatment recovery. We observed growth stimulation with no survival benefit in low dose docetaxel-treated monolayer and spheroid culture. However, agent-based modeling suggested that this hormetic effect may have been influenced by the active process of apoptosis. To the best of our knowledge, this is the first clonogenic measurement of docetaxel-treated spheroid culture and longitudinal observation of post-treatment docetaxel-dose dependent effects in prostate cancer cell culture.

  • Open Access

    Comparison of volumetric dynamic optical coherence tomography with biological methods for evaluation of radiation effects in prostate tumor spheroids

    by Steph Swanson, Keyu Chen, Elahe Cheraghi, Ernest Osei, Kostadinka Bizheva

    Significance: 3D tumor spheroids are more physiologically representative of in vivo patient tumors compared to 2D monolayer culture. However, their 3D nature challenges the use of conventional biological techniques like proliferation assays, fluorescence microscopy, and the clonogenic assay, which is the gold standard method for assessing cell survival following radiation. However, clonogenic assay requires spheroid disaggregation. Aim: Non-invasive volumetric imaging with dynamic optical coherence tomography (dOCT) enables cellular activity to be visualized with spatial resolution within 3D tumor spheroids. Cellular activity observed via dOCT in irradiated prostate tumor spheroids was quantified for comparison with conventional biological techniques. Approach: A Varian TrueBeam linear accelerator was used to irradiate spheroid and monolayer cultures with a 6 MV beam. Cellular activity was estimated from dOCT images generated via frequency banding and compared to clonogenic assay, proliferation assay, fluorescence microscopy, and 3D cell simulation. Results: Prostate cancer cells cultured as spheroids demonstrated improved radio-resistance via clonogenic assay compared to monolayer culture. The dOCT method demonstrated quantitative and qualitative agreement with proliferation assay and fluorescence microscopy, respectively. Conclusions: A longer duration of repeated dOCT measurement in tumor spheroids following radiation treatment could offer a non-invasive alternative to the clonogenic assay.


  • Open Access

    Longitudinal investigation of prostate tumor spheroid proliferation with dynamic line-field optical coherence tomography

    by Steph Swanson, Keyu Chen, Elahe Cheraghi, Ernest Osei, Kostadinka Bizheva

    Recently, it has become widely recognized that culturing cancer cells in vitro in small, 3D aggregates known as tumor spheroids provides a more physiologically relevant model of in vivo tumor behavior compared to 2D monolayer cultures. Dynamic optical coherence tomography (dOCT) is a non-invasive imaging modality that, by analyzing temporal fluctuations in the light scattered from biological tissue, does not require exogenous contrast agents to visualize and quantify cellular activity within 3D cell cultures. However, recent volumetric dOCT studies have encountered challenges due to low acquisition speeds. In this study, we present morphological and dynamic analyses of prostate tumor spheroid growth over a two-week longitudinal period, utilizing volumetric imaging with a line-field dOCT platform. Our method clearly differentiated between active cellular metabolism in live spheroids and the lack of activity in spheroids fixed with formaldehyde. Quantitative validation of the dynamic signal was conducted using the Alamar Blue proliferation assay, while qualitative validation was provided by live/dead fluorescence microscopy.


  • Open Access

    HyperArc brain SRS target coverage variation due to intra-fractional motion for multiple brain lesions of varying separations and sizes

    by Aydin Sanli, Runqing Jiang, Johnson Darko, Ernest Osei

    Purpose: An evaluation was conducted for HyperArc brain stereotactic radiosurgery (SRS) plans to determine the effect of intra-fractional motion on target coverage and dosimetry to understand the safe limits of zero-PTV-margin HyperArc SRS treatments. Material and methods: The Steve phantom was CT scanned with an Encompass mask and imported into the Eclipse Treatment Planning System, version 16·01. Two high-resolution spherical contours (GTV1 and GTV2) were generated with various sizes and separations. The rotational shift was transformed into translation based on the distance from the tumours to the isocentre and the rotational angle between the tumours. The effect of translational shifts corresponding to each rotational shift on dosimetric performance was evaluated for various tumour sizes and distances to the isocentre. Results: The tumour coverage was compared for different tumour sizes and distances to the isocentre due to intra-fractional motion. For tumour sizes less than 6 mm in diameter, the volume coverage changes significantly for separations greater than 5·5 cm from the isocentre. The effects of intra-fractional motion on dosimetry dominate for separations greater than 5·5 cm. Even though the percent volume coverage changes sharply for extreme shifts, the percent dose coverage stays between 70 and 80% for extreme shifts (1·2° in our case) for all lesion sizes. Conclusions: The target-to-isocentre separation and the size of the lesions are two major factors that contribute to significant dosimetric deviations. When the target-to-isocentre distance is within 3·5 cm, D100% is over 90% coverage. Over 90% target coverage is achievable for zero PTV margin in situations where extreme shifts of 1·2° exist.


  • Open Access

    Engineered dual-functional gold nanoparticles enhance radiosensitization in prostate cancer cells: synergistic action of curcumin and gold

    by Mohamed Aborig, Moad Alsefaou, Ernest Osei, Shawn Wettig

    Prostate cancer remains a leading cause of cancer-related mortality in men, with the three main treatment modalities being surgery, chemotherapy, radiotherapy, or a combination depending on the stage. However, the use of radiotherapy is often restricted by dose-limiting toxicity of the organs at risk. To address this challenge, we developed curcumin-coated gold nanoparticles (Curc-GNPs) that leverage both the photoelectric properties of gold and the radiosensitizing effects of curcumin. In this study, we explore the stability, cytotoxicity, cellular uptake, and radio-sensitizing potential of Curc-GNP in PC-3 prostate cancer cells. Curc-GNPs exhibited a biphasic dose–response curve where concentrations up to 100 μg mL−1 showed minimal cytotoxicity, whereas higher doses (>100 μg mL−1) were markedly cytotoxic. Cellular uptake was enhanced under serum-free conditions. Clonogenic survival assays revealed significant radiosensitization (sensitizer enhancement ratio up to 1.82 at 500 μg per mL Curc-GNPs), linked to an elevated α-parameter in the linear–quadratic model and heightened reactive oxygen species production. These results highlight Curc-GNPs as a promising platform for enhancing radiotherapy efficacy in prostate cancer while potentially mitigating off-target toxicity.


  • Patients’ self-reported overall wellbeing correlates with concurrent reported symptoms: analysis of the Edmonton Symptom Assessment System

    by Catherine B. McKenna, Ernest Osei, Brooklynn Fleury, Stephanie Swanson, Christabel Oghinan, Johnson Darko

    Background:The primary intent of cancer treatment is either curative, prolongation of patient life, or to improve patient quality of life; however, treatments are associated with various side effects that may impact patient wellbeing. Thus, understanding the patients’ wellbeing from the patient’s perspective is essential as it could help enable the provision of the necessary support for patients throughout their cancer journey.Materials and Method:We analysed Edmonton Symptom Assessment System (ESAS) questionnaire responses completed by 19,288 patients over 201,839 visits to our Cancer Centre. As part of their routine and standard of care, patients completing the questionnaire are asked to score 6 physical and 2 psychological symptoms as well as overall wellbeing using an 11-point numerical rating scale ranging from 0 to 10, where 0 means complete absence of the symptom or best overall wellbeing and 10 means worst possible symptom or worst overall wellbeing. We used the ESAS responses to characterise the relationship between the overall wellbeing score and concurrent symptoms scored by cancer patients.Results:Patients reported tiredness and nausea as the physical symptom causing the most and least distress respectively. Patients that reported severe (7–10) wellbeing also scored high mean scores for tiredness (6·2 ± 2·7), drowsiness (4·7 ± 3·1) and lack of appetite (4·4 ± 3·4). Univariate and multivariable logistic regression analysis suggests higher odds for patients to report moderate-to-severe (4–10) wellbeing when they report moderate-to-severe concurrent symptoms compared to none-to-mild concurrent symptoms.Conclusions:Our findings suggest that patients’ overall wellbeing as reported by the ESAS system is influenced by a number of concurrent symptoms. Tiredness was found to impact patients’ overall wellbeing to a greater extent than other concurrent symptoms. The sum of physical or psychological symptom scores was stronger indicators of a patient’s overall wellbeing compared to the scores of individual symptoms.


  • Dosimetric evaluation of VMAT treatment plans for patients with stage IIB or III non-small cell lung carcinomas

    by Amani Shaaer, Ernest Osei, Johnson Darko, Darin Gopaul

    Introduction: Volumetric-modulated arc therapy (VMAT) has emerged as a promising radiation treatment technique. One of the challenges in VMAT planning for lung carcinoma is the lack of consistency among different institutions with respect to what is considered an acceptable treatment plan in terms of target coverage and doses to the organs at risk (OAR). Additionally, the accuracy of dose calculations in the presence of heterogeneous medium (i.e. air) is another challenge in lung VMAT planning. Our objective is to develop an institutional criteria for non-stereotactic body radiotherapy (non-SBRT) lung treatment plans by evaluating the dosimetric impact of plan normalisation and dose calculation algorithms, including the Anisotropic Analytical Algorithm (AAA), AcurosXB (AXB) and Monte Carlo (MC) simulation, on VMAT plans for non-small cell lung cancer (NSCLC). Methods: The CT dataset of 20 patients with NSCLC was randomly selected to ensure a spectrum of target sizes and locations. All treatment planning was accomplished with 2–3 VMAT arcs and a prescription of 60 Gy in 30 fractions. Two plan normalisation methods were employed: (i) planning target volume (PTV) V100% = 95% and (ii) PTV V95% = 95%. Results: All three dose calculation algorithms revealed heterogeneous and conformal plans irrespective of plan normalisations. The PTV and OARs dose–volume constraints were met using both normalisation methods. However, we observed that AAA overestimated the minimum PTV doses by 2–5% regardless of plan normalisation. The mean PTV-V100% was lower for AAA in comparison with AXB and MC algorithms. Conclusions: VMAT is an effective radiotherapy technique for achieving greater target dose conformity, heterogeneity and dose fall-off from the PTV for the treatment of NSCLC. The results of this study can provide the basis for the development of local plan acceptability criteria for NSCLC VMAT plans, and the clinical implementation can be achieved with minimal or no imposition on resources and time constraints. Occasionally, plan normalisation of PTV-V95% = 95% may be required to ensure that the OAR dose tolerances are not exceeded.


  • 89: The Radiation Incident Safety Committee Incident Reporting Guidance Tree: A Tool to Aid Provincial and National Incident Sharing

    by Cassandra Costello-Cornfield, Erika Hammer, Tom Farrell, Josef Dubicki, Sara Kaune, Julie Kraus, Brian Liszewski, Lyndon Morley, Gabe Menjolian, Ernest Osei, et al.

  • Systematic self-reporting of patients’ symptoms: improving oncologic care and patients’ satisfaction

    by Ernest Osei, Catherine B. McKenna, Johnson Darko, Kathy McKnight, Christine Peters

    Background: In recent years, there has been a growing interest to enhance patients’ symptom management during routine cancer care using patient-reported outcome measures. The goal of this study is to analyse patients’ responses to the Edmonton Symptom Assessment System (ESAS) to determine whether patient-reported outcomes could help characterise those patients with the highest supportive care needs and symptom burden in order to help provide targeted support for patients. Methods: In this study, we analysed ESAS questionnaire responses completed by patients as part of their routine care and considered part of patients’ standard of care. Statistical analyses were performed using the IBM SPSS Statistics version 26.0. Descriptive statistics are used to summarise patient demographics, disease characteristics and patient-reported symptom severity and prevalence. Results: The overall mean age is 65.2 ± 12.8 years comprising 43.8% male and 56.2% female patients. The five common primary disease sites are breast (26.2%), haematology (21.1%), gastrointestinal (15.3%), genitourinary (12.7%) and lung (12.0%) cancers. The mean severity for each symptom is all mild (score: 1–3). The three most common reported symptoms causing distress are tiredness, poor overall wellbeing and anxiety, and the least reported symptom is nausea. Conclusions: Systematic self-reporting of patients’ symptoms is important to improve symptom management, timely facilitation of appropriate intervention, patient experience, and patient and family satisfaction. The awareness of disease site, gender and age-related symptom variations should help in the design and provision of appropriate symptom-directed, tumour-specific and patient-focused interventions to meet patients’ immediate needs.